go back

Brexucabtagene Autoleucel (Tecartus)

Kentucky rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $52,481 · 10th to 90th $38,905 to $63,096Professionalmedian $51,286 · 10th to 90th $46,774 to $380,189
$50K$100K$200Kfacility $52,481professional $51,286

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
CareSource
Setting
Facility
Modifier
Global
Typical Low
$38,904.51
Median
$52,480.75
Typical High
$63,095.73
CareSource
Setting
Professional
Modifier
Global
Typical Low
$46,773.51
Median
$51,286.14
Typical High
$380,189.40